{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T05:22:33Z","timestamp":1732252953452,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,21]]},"DOI":"10.7759\/cureus.74144","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:07:17Z","timestamp":1732194437000},"source":"Crossref","is-referenced-by-count":0,"title":["Lymphoplasmacytic Lymphoma Presenting as Severe Secondary Raynaud\u2019s Phenomenon"],"prefix":"10.7759","author":[{"given":"Drayton J","family":"Rorah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah","family":"Daghlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashood","family":"Badshah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Maz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh546","article-title":"Pathogenesis of Raynaud's phenomenon","volume":"44","author":"Herrick AL","year":"2005","unstructured":"Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford). 2005, 44:587-96. 10.1093\/rheumatology\/keh546","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000725","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"134","author":"Dimopoulos MA","year":"2019","unstructured":"Dimopoulos MA, Kastritis E. How I treat Waldenstr\u00f6m macroglobulinemia. Blood. 2019, 134:2022-35. 10.1182\/blood.2019000725","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915030-00002","article-title":"Raynaud's phenomenon in older adults: diagnostic considerations and management","volume":"15","author":"Ling SM","year":"1999","unstructured":"Ling SM, Wigley FM. Raynaud's phenomenon in older adults: diagnostic considerations and management. Drugs Aging. 1999, 15:183-95. 10.2165\/00002512-199915030-00002","journal-title":"Drugs Aging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2016.09.006","article-title":"Vasculitic and autoimmune wounds","volume":"5","author":"Shanmugam VK","year":"2017","unstructured":"Shanmugam VK, Angra D, Rahimi H, McNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord. 2017, 5:280-92. 10.1016\/j.jvsv.2016.09.006","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.178039071","article-title":"Familial aggregation of primary Raynaud's disease","volume":"39","author":"Freedman RR","year":"1996","unstructured":"Freedman RR, Mayes MD. Familial aggregation of primary Raynaud's disease. Arthritis Rheum. 1996, 39:1189-91. 10.1002\/art.178039071","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-821x(88)80070-7","article-title":"An epidemiological survey of Raynaud's phenomenon","volume":"2","author":"de Trafford JC","year":"1988","unstructured":"de Trafford JC, Lafferty K, Potter CE, Roberts VC, Cotton LT. An epidemiological survey of Raynaud's phenomenon. Eur J Vasc Surg. 1988, 2:167-70. 10.1016\/s0950-821x(88)80070-7","journal-title":"Eur J Vasc Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006389","article-title":"Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies","volume":"5","author":"Garner R","year":"2015","unstructured":"Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015, 5:e006389. 10.1136\/bmjopen-2014-006389","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000757","article-title":"Cryoglobulinemic vasculitis: pathophysiological mechanisms and diagnosis","volume":"33","author":"Kolopp-Sarda MN","year":"2021","unstructured":"Kolopp-Sarda MN, Miossec P. Cryoglobulinemic vasculitis: pathophysiological mechanisms and diagnosis. Curr Opin Rheumatol. 2021, 33:1-7. 10.1097\/BOR.0000000000000757","journal-title":"Curr Opin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12912","article-title":"Drug-induced Raynaud's phenomenon: beyond \u03b2-adrenoceptor blockers","volume":"82","author":"Khouri C","year":"2016","unstructured":"Khouri C, Blaise S, Carpentier P, Villier C, Cracowski JL, Roustit M. Drug-induced Raynaud's phenomenon: beyond \u03b2-adrenoceptor blockers. Br J Clin Pharmacol. 2016, 82:6-16. 10.1111\/bcp.12912","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21615","article-title":"Risk factors for Raynaud's phenomenon in the workforce","volume":"64","author":"Roquelaure Y","year":"2012","unstructured":"Roquelaure Y, Ha C, Le Manac'h AP, et al.. Risk factors for Raynaud's phenomenon in the workforce. Arthritis Care Res (Hoboken). 2012, 64:898-904. 10.1002\/acr.21615","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1980.00330180106029","article-title":"Raynaud's phenomenon and thyroid deficiency","volume":"140","author":"Shagan BP","year":"1980","unstructured":"Shagan BP, Friedman SA. Raynaud's phenomenon and thyroid deficiency. Arch Intern Med. 1980, 140:832-3.","journal-title":"Arch Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200430","article-title":"Paraneoplastic acral vascular syndrome","volume":"192","author":"Jud P","year":"2020","unstructured":"Jud P, Raggam RB, Hafner F. Paraneoplastic acral vascular syndrome. CMAJ. 2020, 192:E1470. 10.1503\/cmaj.200430","journal-title":"CMAJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0266-7681(97)80392-0","article-title":"Cold intolerance following peripheral nerve injury. Natural history and factors predicting severity of symptoms","volume":"22","author":"Irwin MS","year":"1997","unstructured":"Irwin MS, Gilbert SE, Terenghi G, Smith RW, Green CJ. Cold intolerance following peripheral nerve injury. Natural history and factors predicting severity of symptoms. J Hand Surg Br. 1997, 22:308-16. 10.1016\/s0266-7681(97)80392-0","journal-title":"J Hand Surg Br"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X11398519","article-title":"Acrocyanosis: the Flying Dutchman","volume":"16","author":"Kurklinsky AK","year":"2011","unstructured":"Kurklinsky AK, Miller VM, Rooke TW. Acrocyanosis: the Flying Dutchman. Vasc Med. 2011, 16:288-301. 10.1177\/1358863X11398519","journal-title":"Vasc Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000333148","article-title":"Age-dependent changes in temperature regulation - a mini review","volume":"58","author":"Blatteis CM","year":"2012","unstructured":"Blatteis CM. Age-dependent changes in temperature regulation - a mini review. Gerontology. 2012, 58:289-95. 10.1159\/000333148","journal-title":"Gerontology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105561","article-title":"Coexistence of erythromelalgia and Raynaud's phenomenon","volume":"90","author":"Chatterjee S","year":"2023","unstructured":"Chatterjee S. Coexistence of erythromelalgia and Raynaud's phenomenon. Joint Bone Spine. 2023, 90:105561. 10.1016\/j.jbspin.2023.105561","journal-title":"Joint Bone Spine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp013015","article-title":"Clinical practice. Raynaud's phenomenon","volume":"347","author":"Wigley FM","year":"2002","unstructured":"Wigley FM. Clinical practice. Raynaud's phenomenon. N Engl J Med. 2002, 347:1001-8. 10.1056\/NEJMcp013015","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.10.17","article-title":"Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management","volume":"5","author":"McMahan ZH","year":"2010","unstructured":"McMahan ZH, Wigley FM. Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management. Int J Clin Rheumtol. 2010, 5:355-70. 10.2217\/ijr.10.17","journal-title":"Int J Clin Rheumtol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud's phenomenon","volume":"375","author":"Wigley FM","year":"2016","unstructured":"Wigley FM, Flavahan NA. Raynaud's phenomenon. N Engl J Med. 2016, 375:556-65. 10.1056\/NEJMra1507638","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri C","year":"2004","unstructured":"Ferri C, Sebastiani M, Giuggioli D, et al.. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004, 33:355-74. 10.1016\/j.semarthrit.2003.10.001","journal-title":"Semin Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259831-lymphoplasmacytic-lymphoma-presenting-as-severe-secondary-raynauds-phenomenon","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:07:20Z","timestamp":1732194440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259831-lymphoplasmacytic-lymphoma-presenting-as-severe-secondary-raynauds-phenomenon"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.74144","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}